Trademark: 97176337
Word
ZIFTALSI
Status Date
Wednesday, May 22, 2024
Filing Date
Thursday, December 16, 2021
Published for Opposition
Tuesday, November 1, 2022
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Sep 26, 2022
Approved For Pub - Principal Register
Dec 20, 2021
New Application Entered
Dec 21, 2021
New Application Office Supplied Data Entered
Sep 22, 2022
Assigned To Examiner
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Nov 1, 2022
Published For Opposition
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 27, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 13, 2023
Assigned To Examiner
May 25, 2023
Sou Teas Extension Received
May 25, 2023
Sou Extension 1 Filed
May 25, 2023
Sou Extension 1 Granted
May 27, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2023
Sou Teas Extension Received
Nov 29, 2023
Sou Extension 2 Filed
Nov 29, 2023
Sou Extension 2 Granted
Nov 30, 2023
Notice Of Approval Of Extension Request E-Mailed
May 22, 2024
Sou Teas Extension Received
May 22, 2024
Sou Extension 3 Filed
May 22, 2024
Sou Extension 3 Granted
May 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
